Psychemedics Corporation
PMD was delisted on the 12th of December, 2024.
54 hedge funds and large institutions have $49.4M invested in Psychemedics Corporation in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 19 reducing their positions, and 5 closing their positions.
0% more funds holding
Funds holding: 54 → 54 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
15% less capital invested
Capital invested by funds: $58M → $49.4M (-$8.61M)
21% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 19
Top Buyers
Top Sellers
PMD Hedge Fund Activity: Q4 2018 in Review
54 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q4 2018, worth a combined $49.4M — down 15% from $58M a quarter earlier.
Fund positioning in PMD was balanced in Q4 2018: 5 funds opened new positions, 5 closed out, 15 added to existing stakes and 19 trimmed.
The largest buyer was Kennedy Capital Management, adding an estimated $1.38M. The largest seller was Susquehanna International Group, exiting entirely with an estimated $714K sold.
- 54 institutional investors held Psychemedics Corporation (PMD) as of Q4 2018, unchanged from Q3 2018.
- Funds reported $49.4M of Psychemedics Corporation stock for Q4 2018, down 15% quarter-over-quarter.
- 5 funds opened new Psychemedics Corporation positions in Q4 2018 and 5 closed out, a net change of 0 holders.
- The largest Psychemedics Corporation buyer in Q4 2018 was Kennedy Capital Management, an estimated $1.38M added.
- The largest Psychemedics Corporation seller in Q4 2018 was Susquehanna International Group, an estimated $714K sold.
Based on aggregated 13F filings for Q4 2018.